A promising anti-cancer therapy works great at first, but then loses its punch. A clever workaround may provide high-octane efficacy, without side effects.
Stanford Storybank, organized by Stanford Health Care, collects 40-minute audio stories from patients and members of the Stanford Medicine community.
After Aditi Polamreddy's brain tumor was removed, she needed physical and occupational therapy to keep her brain from forgetting one side of her body.
This Stanford Medicine study clarifies the underlying biology of high-grade serous ovarian cancer and could help lead to future therapies.
Douglas Lowy, deputy director of the National Cancer Institute, recently spoke at Stanford Medicine.
Stanford researchers led work on a possible cancer vaccine that involves injecting two immune-stimulating agents directly into solid tumors.
When Jeff Schottenstein's wife was diagnosed with gastric cancer in 2014, he immediately jumped into action and left no stone un-turned in researching potential solutions to …
To explain her work, Stanford chemistry professor Carolyn Bertozzi, PhD, often turns to analogies. Cancer cells, she says, are like M&M'S with a hard sugar coating. …
There's a new kid on the block in cancer treatment. Actually it's an old kid who's been around for awhile but is being heralded …
The prostate-specific antigen (PSA) test has become a first-resort workhorse for determining whether a male patient needs to be biopsied for prostate cancer. Simply put, …
